Index by author

November 01, 2004; Volume 71,Issue 11

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Simon, Lee S.
1. You have access
  A world without Vioxx: To COX-2 or not to COX-2?
  Lee S. Simon, MD and Vibeke Strand, MD
  
  Cleveland Clinic Journal of Medicine November 2004, 71 (11) 849-856;
  
  Are all selective COX-2 inhibitors associated with an increased risk for thromboembolic cardiovascular events? And what should we tell patients?
Strand, Vibeke
1. You have access
  A world without Vioxx: To COX-2 or not to COX-2?
  Lee S. Simon, MD and Vibeke Strand, MD
  
  Cleveland Clinic Journal of Medicine November 2004, 71 (11) 849-856;
  
  Are all selective COX-2 inhibitors associated with an increased risk for thromboembolic cardiovascular events? And what should we tell patients?
Walmsley, Konstantin
1. You have access
  Benign prostatic hyperplasia: Now we can begin to tailor treatment
  Carl K. Gjertson, MD, Konstantin Walmsley, MD and Steven A. Kaplan, MD
  
  Cleveland Clinic Journal of Medicine November 2004, 71 (11) 857-880;
  
  The management of benign prostatic hyperplasia has improved considerably in recent years. A review of medications, surgery, and new minimally invasive procedures.